1832 Asset Management
LCTX icon

1832 Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

1832 Asset Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$5 – 933
2022
Q4 		$5 Hold
5
– – ﹤0.01% 878
2022
Q3 		$0 Buy
+5
New – ﹤0.01% 884